# Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy

> **NCT00346853** · PHASE1 · COMPLETED · sponsor: **University of Utah** · enrollment: 10 (actual)

## Conditions studied

- Macular Dystrophy, Corneal

## Interventions

- **DRUG:** 4-Methylpyrazole
- **OTHER:** saline

## Key facts

- **NCT ID:** NCT00346853
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2006-05
- **Final completion:** 2006-09
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00346853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00346853, "Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00346853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*